The pro‐inflammatory environment in recalcitrant diabetic foot wounds JB Acosta, D Garcia del Barco, D Cibrian Vera, W Savigne, ... International wound journal 5 (4), 530-539, 2008 | 250 | 2008 |
Epidermal growth factor in clinical practice–a review of its biological actions, clinical indications and safety implications J Berlanga‐Acosta, J Gavilondo‐Cowley, P López‐Saura, ... International wound journal 6 (5), 331-346, 2009 | 202 | 2009 |
A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: report of a pilot clinical trial G Gonzalez, T Crombet, M Catala, V Mirabal, JC Hernández, Y González, ... Annals of oncology 9 (4), 431-435, 1998 | 200 | 1998 |
Glucose toxic effects on granulation tissue productive cells: the diabetics’ impaired healing J Berlanga-Acosta, GS Schultz, E López-Mola, G Guillen-Nieto, ... BioMed research international 2013 (1), 256043, 2013 | 165 | 2013 |
A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates L Hermida, L Bernardo, J Martín, M Alvarez, I Prado, C López, BC Sierra, ... Vaccine 24 (16), 3165-3171, 2006 | 158 | 2006 |
Domain III of the envelope protein as a dengue vaccine target MG Guzman, L Hermida, L Bernardo, R Ramirez, G Guillén Expert review of vaccines 9 (2), 137-147, 2010 | 146 | 2010 |
Development of a nasal vaccine for chronic hepatitis B infection that uses the ability of hepatitis B core antigen to stimulate a strong Th1 response against hepatitis B … JC Aguilar, Y Lobaina, V Muzio, D García, E Pentón, E Iglesias, ... Immunology and cell biology 82 (5), 539-546, 2004 | 138 | 2004 |
Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines R Züst, YX Toh, I Valdés, D Cerny, J Heinrich, L Hermida, E Marcos, ... Journal of virology 88 (13), 7276-7285, 2014 | 117 | 2014 |
Epidermal growth factor intralesional infiltrations can prevent amputation in patients with advanced diabetic foot wounds JB Acosta, W Savigne, C Valdez, N Franco, JS Alba, A Rio, ... International wound journal 3 (3), 232-239, 2006 | 117 | 2006 |
C-Phycocyanin is neuroprotective against global cerebral ischemia/reperfusion injury in gerbils G Pentón-Rol, J Marín-Prida, G Pardo-Andreu, G Martínez-Sánchez, ... Brain research bulletin 86 (1-2), 42-52, 2011 | 115 | 2011 |
Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial) M Al Mahtab, SMF Akbar, JC Aguilar, G Guillen, E Penton, A Tuero, ... PLoS One 13 (8), e0201236, 2018 | 113 | 2018 |
Immune response to synthetic peptides of dengue prM protein S Vázquez, MG Guzmán, G Guillen, G Chinea, AB Pérez, M Pupo, ... Vaccine 20 (13-14), 1823-1830, 2002 | 111 | 2002 |
Diabetic foot ulcers and epidermal growth factor: revisiting the local delivery route for a successful outcome J Berlanga-Acosta, J Fernández-Montequín, C Valdés-Pérez, ... BioMed research international 2017 (1), 2923759, 2017 | 103 | 2017 |
C-Phycocyanin ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells G Pentón-Rol, G Martínez-Sánchez, M Cervantes-Llanos, ... International Immunopharmacology 11 (1), 29-38, 2011 | 92 | 2011 |
Wound chronicity, impaired immunity and infection in diabetic patients N Rodríguez-Rodríguez, I Martínez-Jiménez, A García-Ojalvo, ... MEDICC review 24, 44-58, 2022 | 90 | 2022 |
Outer membrane vesicles of the VA‐MENGOC‐BC® vaccine against serogroup B of Neisseria meningitidis: Analysis of protein components by two‐dimensional … L Uli, L Castellanos‐Serra, L Betancourt, F Domínguez, R Barberá, ... Proteomics 6 (11), 3389-3399, 2006 | 90 | 2006 |
Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates L Bernardo, A Izquierdo, M Alvarez, D Rosario, I Prado, C López, ... Antiviral research 80 (2), 194-199, 2008 | 87 | 2008 |
A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in mice I Valdés, L Bernardo, L Gil, A Pavón, L Lazo, C López, Y Romero, ... Virology 394 (2), 249-258, 2009 | 85 | 2009 |
Cellular senescence as the pathogenic hub of diabetes-related wound chronicity JA Berlanga-Acosta, GE Guillén-Nieto, N Rodríguez-Rodríguez, ... Frontiers in Endocrinology 11, 573032, 2020 | 81 | 2020 |
Insulin resistance at the crossroad of Alzheimer disease pathology: A review J Berlanga-Acosta, G Guillén-Nieto, N Rodríguez-Rodríguez, ... Frontiers in endocrinology 11, 560375, 2020 | 79 | 2020 |